"The start-up has raised $118 million in funding from investors including CRV and Menlo Ventures, and it reached more than $100 million in revenue in 2017, the company says. In 2016 it was reported to be valued at $330 million."
Some perspective for RXMD valuation: $100 million revenue is less than 5x RXMD's $22 million. Leads to some intriguing math and comparisons.